Bridge expands China operations with new lab
This article was originally published in Scrip
Bridge Laboratories is to start constructing a second Chinese research facility in Beijing in the fourth quarter of this year. The 150,000 sq ft building in the city's Zhongguancun Life Science Park is due for completion, in compliance withUS and international regulatory standards, in the fourth quarter of next year . It will provide a range of preclinical contract services, in areas including toxicology, immunology, vaccines and bioanalyis.. The facility will quadruple the US contract research firm's laboratory space in China, it says.